XML 53 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Description of Business and Significant Accounting Policies - Additional Information (Detail)
1 Months Ended 6 Months Ended
Jan. 31, 2022
USD ($)
Jun. 30, 2021
USD ($)
Apr. 30, 2021
USD ($)
Jun. 30, 2023
USD ($)
Segment
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Jul. 01, 2013
USD ($)
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Accumulated deficit       $ (3,232,529,000)   $ (3,217,469,000)    
Cash and cash equivalents       86,184,000   69,767,000    
Short-term investments       58,163,000   101,079,000    
Long-term investments       2,282,000   1,961,000    
Financing liability       $ 104,100,000   104,100,000    
Number of operating segment | Segment       1        
Purchase of available-for-sale investment         $ 5,000,000      
Milestone Rights Payment       $ 5,000,000        
Maximum | AFREZZA product sales                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Sales return right following product expiration in months       12 months        
Minimum | AFREZZA product sales                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Sales return right following product expiration in months       6 months        
Convertible Promissory Note | Thirona Bio, Inc.                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Purchase of available-for-sale investment $ 5,000,000.0 $ 3,000,000.0            
Interest rate       6.00%        
MidCap Credit Facility                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Principal amount [1]       $ 40,000,000   $ 40,000,000    
Principal prepayment against outstanding term loans     $ 10,000,000.0          
MidCap Credit Facility | Tranche Three                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Amount available under credit facility     $ 60,000,000.0 60,000,000.0     $ 25,000,000.0  
Milestone Rights Liability | Deerfield                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Contingent liability remain payable       $ 60,000,000.0       $ 60,000,000.0
Milestone Rights Liability | Maximum | Deerfield                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Contingent liability for milestone payments               $ 90,000,000.0
[1] In August 2022, the Company amended the MidCap credit facility and transitioned the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (“SOFR”).